127 related articles for article (PubMed ID: 7506374)
1. Series: 'Current issues in mutagenesis and carcinogenesis.' No. 41. Can a 'relatively simple' screening procedure for the detection of chemicals with aneugenic potential be recommended at the moment?
Miller BM; Madle S; Albertini S
Mutat Res; 1994 Jan; 304(2):303-7. PubMed ID: 7506374
[No Abstract] [Full Text] [Related]
2. Research on the mechanisms of action of aneugenic chemicals and regulatory approaches for their control in the European Communities.
Parry JM
Environ Mol Mutagen; 1996; 28(3):248-53. PubMed ID: 8908183
[TBL] [Abstract][Full Text] [Related]
3. Series: 'Current issues in mutagenesis and carcinogenesis.' No. 42. Strategies and philosophies of genotoxicity testing: what is the question?
Zeiger E
Mutat Res; 1994 Jan; 304(2):309-14. PubMed ID: 7506375
[TBL] [Abstract][Full Text] [Related]
4. Series: 'Current issues in mutagenesis and carcinogenesis.' No. 43. Mutations among the living and the undead.
Burkhart JG; Malling HV
Mutat Res; 1994 Jan; 304(2):315-20. PubMed ID: 7506376
[No Abstract] [Full Text] [Related]
5. Comparisons of tests for aneuploidy.
Parry JM; Parry EM
Mutat Res; 1987 Dec; 181(2):267-87. PubMed ID: 3317028
[TBL] [Abstract][Full Text] [Related]
6. Aneuploidy: a report of an ECETOC task force.
Aardema MJ; Albertini S; Arni P; Henderson LM; Kirsch-Volders M; Mackay JM; Sarrif AM; Stringer DA; Taalman RD
Mutat Res; 1998 Feb; 410(1):3-79. PubMed ID: 9587424
[TBL] [Abstract][Full Text] [Related]
7. The analysis of the activity of aneugenic chemicals, from cultured cells to rodent zygotes: an overview of the Protection of the European Population from Aneugenic Chemicals (PEPFAC project).
Parry JM
Mutat Res; 2008 Mar; 651(1-2):1-2. PubMed ID: 18082443
[No Abstract] [Full Text] [Related]
8. Detection and characterization of mechanisms of action of aneugenic chemicals.
Parry EM; Parry JM; Corso C; Doherty A; Haddad F; Hermine TF; Johnson G; Kayani M; Quick E; Warr T; Williamson J
Mutagenesis; 2002 Nov; 17(6):509-21. PubMed ID: 12435848
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo extrapolations of genotoxin exposures: consideration of factors which influence dose-response thresholds.
Parry JM; Jenkins GJ; Haddad F; Bourner R; Parry EM
Mutat Res; 2000 Jan; 464(1):53-63. PubMed ID: 10633177
[TBL] [Abstract][Full Text] [Related]
10. The detection and assessment of the aneugenic potential of environmental chemicals: the European Community Aneuploidy Project.
Parry JM; Sors A
Mutat Res; 1993 May; 287(1):3-15. PubMed ID: 7683383
[TBL] [Abstract][Full Text] [Related]
11. Development of screening tests for aneuploidy induction by environmental pollutants.
Adler ID; Parry JM
Environ Health Perspect; 1993 Oct; 101 Suppl 3(Suppl 3):5-9. PubMed ID: 8143646
[TBL] [Abstract][Full Text] [Related]
12. Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals.
Mortelmans K; Haworth S; Lawlor T; Speck W; Tainer B; Zeiger E
Environ Mutagen; 1986; 8 Suppl 7():1-119. PubMed ID: 3516675
[TBL] [Abstract][Full Text] [Related]
13. A comparison of two in vitro mammalian cell cytogenetic assays for the detection of mitotic aneuploidy using 10 known or suspected aneugens.
Warr TJ; Parry EM; Parry JM
Mutat Res; 1993 May; 287(1):29-46. PubMed ID: 7683382
[TBL] [Abstract][Full Text] [Related]
14. The detection and evaluation of aneugenic chemicals.
Parry JM; Parry EM; Bourner R; Doherty A; Ellard S; O'Donovan J; Hoebee B; de Stoppelaar JM; Mohn GR; Onfelt A; Renglin A; Schultz N; Söderpalm-Berndes C; Jensen KG; Kirsch-Volders M; Elhajouji A; Van Hummelen P; Degrassi F; Antoccia A; Cimini D; Izzo M; Tanzarella C; Adler ID; Kliesch U; Hess P
Mutat Res; 1996 Jun; 353(1-2):11-46. PubMed ID: 8692188
[TBL] [Abstract][Full Text] [Related]
15. The use of L5178Y mouse lymphoma cells to assess the mutagenic, clastogenic and aneugenic properties of chemicals.
Combes RD; Stopper H; Caspary WJ
Mutagenesis; 1995 Sep; 10(5):403-8. PubMed ID: 8544753
[TBL] [Abstract][Full Text] [Related]
16. Strategies and testing methods for identifying mutagenic risks.
MacGregor JT; Casciano D; Müller L
Mutat Res; 2000 Nov; 455(1-2):3-20. PubMed ID: 11113464
[TBL] [Abstract][Full Text] [Related]
17. The mouse lymphoma assay in the wake of ICH4--where are we now?
Cole J; Harrington-Brock K; Moore MM
Mutagenesis; 1999 May; 14(3):265-70. PubMed ID: 10374993
[No Abstract] [Full Text] [Related]
18. Aneuploidy and health risk assessment: current status and future directions.
Dellarco VL; Mavournin KH; Tice RR
Environ Mutagen; 1985; 7(3):405-24. PubMed ID: 4043023
[TBL] [Abstract][Full Text] [Related]
19. Assessing the use of known mutagens to calibrate the Salmonella typhimurium mutagenicity assay: II. With exogenous activation.
Claxton LD; Houk VS; Warner JR; Myers LE; Hughes TJ
Mutat Res; 1991 Oct; 253(2):149-59. PubMed ID: 1922141
[TBL] [Abstract][Full Text] [Related]
20. Understanding aneuploidy.
Siegel DH; Sybert VP
Pediatr Dermatol; 2005; 22(3):270-5. PubMed ID: 15916583
[No Abstract] [Full Text] [Related]
[Next] [New Search]
